Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-01 Sale |
2022-02-02 4:50 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
375 | $40.58 | $15,218 | 103,566 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-01 5:58 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
1,233 | $38.47 | $47,434 | 53,857 (Direct) |
View |
| 2022-01-14 Sale |
2022-01-19 8:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $40.56 | $50,700 | 703,003 (Indirect Direct) |
View |
| 2022-01-14 Sale |
2022-01-19 8:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
375 | $40.56 | $15,210 | 143,963 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 4:07 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
375 | $47.31 | $17,741 | 70,354 (Direct) |
View |
| 2021-12-27 Sale |
2021-12-28 5:38 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
1,200 | $48.5 | $58,200 | 117,534 (Indirect Direct) |
View |
| 2021-12-22 Sale |
2021-12-23 4:58 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
10,571 | $47.81 | $505,373 | 182,067 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-21 Option Award(A) |
2022-02-07 8:06 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
33,648 | $0 | 44,020 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
434 | $38.59 | 28,582 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
434 | $38.59 | 20,530 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
434 | $38.59 | 32,989 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:07 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
650 | $38.59 | 103,941 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
650 | $38.59 | 35,555 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
650 | $38.59 | 104,278 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
650 | $38.59 | 142,935 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:01 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
800 | $38.59 | 44,908 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
931 | $38.59 | 894,707 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
2,024 | $38.59 | 1,572,874 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 5:59 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
434 | $38.59 | 23,474 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 5:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
642 | $38.59 | 53,857 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:58 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
63,002 | $0 | 92,683 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:58 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
256,916 | $0 | 1,725,570 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:57 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
74,457 | $0 | 148,598 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:56 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
63,002 | $0 | 932,589 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:55 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
63,002 | $0 | 82,659 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:55 pm |
N/A 2032-01-21 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
63,002 | $0 | 141,542 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:51 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
63,002 | $0 | 73,156 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:50 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
63,002 | $0 | 70,374 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:49 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
63,002 | $0 | 180,536 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:40 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
42,240 | $0 | 48,682 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:39 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
42,240 | $0 | 53,790 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:37 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
25,616 | $0 | 35,988 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:36 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
16,866 | $0 | 25,348 (Direct) |
View |
| 2022-01-21 Exercise |
2022-01-24 5:26 pm |
N/A 2028-04-12 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
3,021 | $0 | 164,178 (Direct) |
View |
| 2022-01-21 Exercise |
2022-01-24 5:26 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
3,021 | $26.73 | 164,178 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 8:15 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 703,003 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 8:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 703,003 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 8:03 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
3,400 | $0 | 143,963 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 8:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
3,400 | $4.31 | 143,963 (Direct) |
View |
| 2022-01-12 Exercise |
2022-01-14 4:57 pm |
N/A 2026-02-06 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
5,161 | $0 | 144,338 (Direct) |
View |
| 2022-01-12 Exercise |
2022-01-14 4:57 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
1,500 | $4.31 | 144,338 (Direct) |
View |
| 2022-01-12 Exercise |
2022-01-14 4:57 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
3,661 | $3.76 | 144,338 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 9:29 pm |
N/A 2029-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director |
12,784 | $0 | 12,784 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 9:28 pm |
N/A 2029-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
12,784 | $0 | 17,784 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 9:28 pm |
N/A 2029-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
12,784 | $0 | 684,278 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 4:41 pm |
N/A 2029-12-31 |
Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director |
12,784 | $0 | 12,784 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 4:38 pm |
N/A 2029-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
12,784 | $0 | 380,357 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 4:58 pm |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
20,112 | $0 | 182,067 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
10,000 | $13.85 | 182,067 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
10,112 | $14.95 | 182,067 (Direct) |
View |
| 2021-12-22 Tax Withholding |
2021-12-23 4:49 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
89 | $47.82 | 7,372 (Direct) |
View |